Secondary analysis of clinical trials--a cautionary note.
暂无分享,去创建一个
[1] R Brian Haynes,et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial , 1999, The Lancet.
[2] G H Guyatt,et al. A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.
[3] G. Guyatt,et al. Users' Guides to the Medical Literature: IX. A Method for Grading Health Care Recommendations , 1995 .
[4] P. Sleight. Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them! , 2000, Current controlled trials in cardiovascular medicine.
[5] J. Habbema,et al. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? , 2006, American heart journal.
[6] R J Cook,et al. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. , 1995, JAMA.
[7] D. DeMets,et al. Fundamentals of Clinical Trials , 1982 .
[8] S. Assmann,et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.
[9] Xin Sun,et al. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses , 2010, BMJ : British Medical Journal.
[10] G. Guyatt,et al. Users' guides to the medical literature. , 1993, JAMA.
[11] Robert M Califf,et al. Lessons learned from recent cardiovascular clinical trials: Part II. , 2002, Circulation.
[12] Robert M Califf,et al. Lessons learned from recent cardiovascular clinical trials: Part I. , 2002, Circulation.
[13] Thomas R Fleming,et al. Clinical Trials: Discerning Hype From Substance , 2010, Annals of Internal Medicine.